Search research articles
Contact Us
Filters
Showing results (41-50 of 109) with videos related to
Page
of 11
Sort By:
Frontiers in Endocrinology
|
June 1, 2012
Angiotensin II, a Neuropeptide at the Frontier between Endocrinology and Neuroscience: Is There a Link between the Angiotensin II Type 2 Receptor and Alzheimer's Disease?
Nicole Gallo-Payet, Marie-Odile Guimond, Lyne Bilodeau, et al.
Journal of Medicinal Chemistry
|
December 13, 2005
A new class of HIV-1 protease inhibitors containing a tertiary alcohol in the transition-state mimicking scaffold
Jenny K Ekegren, Torsten Unge, Mayada Zreik Safa, et al.
Bioorganic & Medicinal Chemistry
|
July 25, 2003
New inhibitors of the malaria aspartyl proteases plasmepsin I and II
Anders Dahlgren, Ingemar Kvarnström, Lotta Vrang, et al.
Bioorganic & Medicinal Chemistry
|
March 5, 2003
A frame shifted disulfide bridged analogue of angiotensin II
Boris Schmidt, Christian Kühn, Dennis K Ehlert, et al.
Journal of Medicinal Chemistry
|
November 13, 2004
AT2-selective angiotensin II analogues containing tyrosine-functionalized 5,5-bicyclic thiazabicycloalkane dipeptide mimetics
Petra Johannesson, Máté Erdélyi, Gunnar Lindeberg, et al.
European Journal of Medicinal Chemistry
|
December 10, 2009
P2'-truncated BACE-1 inhibitors with a novel hydroxethylene-like core
Jenny Adrian Meredith, Catarina Björklund, Hans Adolfsson, et al.
Journal of Neurochemistry
|
September 27, 2019
Insulin-regulated aminopeptidase inhibitor-mediated increases in dendritic spine density are facilitated by glucose uptake
Benjamin Seyer, Shanti Diwakarla, Peta Burns, et al.
Biochimica Et Biophysica Acta
|
April 2, 2004
Structure-activity relationships for the selectivity of hepatitis C virus NS3 protease inhibitors
Anton Poliakov, Anja Johansson, Eva Akerblom, et al.
European Journal of Medicinal Chemistry
|
November 21, 2009
Design and synthesis of novel P2 substituents in diol-based HIV protease inhibitors
Jenny Adrian Meredith, Hans Wallberg, Lotta Vrang, et al.
Bioorganic & Medicinal Chemistry
|
April 20, 2006
A new structural theme in C2-symmetric HIV-1 protease inhibitors: ortho-substituted P1/P1' side chains
Johan Wannberg, Yogesh A Sabnis, Lotta Vrang, et al.
Page
of 11
Search research articles
Search
Showing results (41-50 of 109) with videos related to
Sort By:
Page
of 11
Frontiers in Endocrinology
|
June 1, 2012
Angiotensin II, a Neuropeptide at the Frontier between Endocrinology and Neuroscience: Is There a Link between the Angiotensin II Type 2 Receptor and Alzheimer's Disease?
Nicole Gallo-Payet, Marie-Odile Guimond, Lyne Bilodeau, et al.
Journal of Medicinal Chemistry
|
December 13, 2005
A new class of HIV-1 protease inhibitors containing a tertiary alcohol in the transition-state mimicking scaffold
Jenny K Ekegren, Torsten Unge, Mayada Zreik Safa, et al.
Bioorganic & Medicinal Chemistry
|
July 25, 2003
New inhibitors of the malaria aspartyl proteases plasmepsin I and II
Anders Dahlgren, Ingemar Kvarnström, Lotta Vrang, et al.
Bioorganic & Medicinal Chemistry
|
March 5, 2003
A frame shifted disulfide bridged analogue of angiotensin II
Boris Schmidt, Christian Kühn, Dennis K Ehlert, et al.
Journal of Medicinal Chemistry
|
November 13, 2004
AT2-selective angiotensin II analogues containing tyrosine-functionalized 5,5-bicyclic thiazabicycloalkane dipeptide mimetics
Petra Johannesson, Máté Erdélyi, Gunnar Lindeberg, et al.
European Journal of Medicinal Chemistry
|
December 10, 2009
P2'-truncated BACE-1 inhibitors with a novel hydroxethylene-like core
Jenny Adrian Meredith, Catarina Björklund, Hans Adolfsson, et al.
Journal of Neurochemistry
|
September 27, 2019
Insulin-regulated aminopeptidase inhibitor-mediated increases in dendritic spine density are facilitated by glucose uptake
Benjamin Seyer, Shanti Diwakarla, Peta Burns, et al.
Biochimica Et Biophysica Acta
|
April 2, 2004
Structure-activity relationships for the selectivity of hepatitis C virus NS3 protease inhibitors
Anton Poliakov, Anja Johansson, Eva Akerblom, et al.
European Journal of Medicinal Chemistry
|
November 21, 2009
Design and synthesis of novel P2 substituents in diol-based HIV protease inhibitors
Jenny Adrian Meredith, Hans Wallberg, Lotta Vrang, et al.
Bioorganic & Medicinal Chemistry
|
April 20, 2006
A new structural theme in C2-symmetric HIV-1 protease inhibitors: ortho-substituted P1/P1' side chains
Johan Wannberg, Yogesh A Sabnis, Lotta Vrang, et al.
Page
of 11